KemPharm Inc (OTCQB:KMPH)

0.435
Delayed Data
As of 12:00am ET
 +0.0167 / +4.00%
Today’s Change
0.12
Today|||52-Week Range
1.37
+14.68%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$27.4M

Company Description

KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses in the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Coralville, IA.

Contact Information

KemPharm, Inc.
1180 Celebration Boulevard
Celebration Florida 34747
P:(321) 939-3416
Investor Relations:

Employees

Shareholders

Other institutional8.26%
Individual stakeholders11.34%
Mutual fund holders1.42%

Top Executives

Travis C. MickleChairman, President & Chief Executive Officer
Christal M. M. MickleVice President-Operations & Product Development
R. LaDuane CliftonChief Financial Officer, Secretary & Treasurer
Sven GuentherExecutive Vice President-Research & Development
Timothy J. SangiovanniVice President & Controller